Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab and Radiotherapy in RAS Wildtype Rectal Cancer
NCT01257360Phase 2Unknown
- Sponsor
- Wisp
- Start
- Dec 2010
- Primary completion
- Jan 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in rectal cancer, sponsored by Wisp. Status: unknown.
02
Drugs
panitumumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01257360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257360.